April 27, 2021 – Ortho Clinical Diagnostics (Raritan, NJ) was recognized with a prestigious silver 2021 Edison Award for its VITROS COVID-19 testing solutions, helping labs meet demands of the pandemic with reliable mass-scale testing options.
The Edison Awards is an annual competition honoring excellence in new product and service development, marketing, design and innovation.
The awards committee recognized Ortho’s VITROS Anti-SARS-CoV-2 Total and IgG Antibody Tests and VITROS SARS-CoV-2 Antigen Test in the Innovation subcategory for Accelerated Testing Solutions after reviewing more than 7,000 products and services and over 400 nominations for new products and services development.
This is Ortho’s fourth Edison Award.
Ortho’s third COVID-19 solution, the VITROS SARS-CoV-2 Antigen Test, helps confirm whether a patient has an active infection by detecting viral proteins in swab samples. The test, the first high-throughput antigen test with EUA, has utility for mass-scale testing and delivers same-day results to help hospitals and reference labs address issues of testing backlogs, supply shortages and delayed results.
The test also received CE Mark in November 2020.